Search
for
Sort by
Research 271–300 of 280
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
- Nothing about us, without us: Are we asking the right questions in transgender research?
- Skin Manifestations of Rheumatological Diseases
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- The association between serum zinc levels and subjective symptoms in zinc deficiency patients with chronic liver disease
- Interleukin-1 and Keratinocyte Growth Factor/Fibroblast Growth Factor-7 Gene Expression in Skin Experimental Irritant Contact Dermatitis Mouse Model Treated with Aqueous Extract of Trachyspermum copticum (L.) Link Seeds
- The First Visit: Consult and Workup Before Sperm Banking
- Acrodermatitis Enteropathica in an adult: a case report
- Rumpel-Leede Phenomenon Associated with Pneumatic Compression: A Case Report
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Lichenoid dermatitis from interferon alpha-2a in a patient with metastatic renal cell carcinoma and seronegative HCV
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Familial and Sporadic Porphyria Cutanea Tarda
- High dose interferon treatment in chronic hepatitis C.
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Skin diseases associated with hepatitis C virus: Facts and controversies
- Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review)
- Lichen Planus Pigmentosus as a Cutaneous Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection: A Case Report
- Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- Alopecia areata after hepatitis C virus infection treatment: a case report
- Erosive Lichen Planus of the Scalp and Hepatitis C Infection
- Molecular Mechanism of Avicennia marina (Forssk.) Vierh. in Inhibiting Hepatitis C Virus Based on Network Pharmacology and Molecular Docking
- Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease
- Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C